ActiPatch ...one of five breakthrough

New Post Public Reply Private Reply Replies (0) Message Board
Chanel5
360
ActiPatch ...one of five breakthrough technologies....


With opioid epidemic on the rise, medical researchers and professionals are continuously on the lookout for alternative methods to provide relief to patients with chronic pain.

In this article, Dr. Tom Macek shares with you the five breakthrough technologies that are helping patients manage their pain.

1. HEAT Pain Pro™ TENS Device

The HEAT Pain Pro combines heat with transcutaneous electrical nerve stimulation or TENS to relieve chronic muscle and joint pain. The most remarkable thing about this device is that it is available over the counter at any drug store.

TENS provide pain relief by transmitting electrical pulses across the skin and alongside nerves, therefore, preventing the brain from receiving any pain signals. The electrical stimulation also releases endorphins in the body which are a natural pain reliever.

Even though this technique is already in use by physical therapists around the world, the HEAT Pain Pro is the first device of its kind available for consumers. Before the advent of this technology, TENS was only conducted by doctors and health care specialists.

2. Radiofrequency Ablation Devices

Radiofrequency therapy is the use of medium frequency (350-500 kHz) alternating current device to generate heat and enervate tissues that make up the peripheral nervous system. If the therapy is completed using a catheter then we call it radiofrequency catheter ablation. This process is minimally invasive and a substitute for surgery.

The demand for radiofrequency ablation is projected to increase in the near future due to the increasing numbers of people suffering from chronic pain and the steadily rising population of geriatric patients. A study conducted by researchers in 2014 revealed that more than half the patients from a group of 77 felt relief from pain for up to 6 months following the radiofrequency therapy.

The pros of choosing this technology include avoiding all complications, recovery time and adverse effects related to surgery. Another added benefit is that the device is easily available and cost-efficient.

3. ActiPatch®

Another non-invasive is the electroceutical device ActiPatch that makes the use of electromagnetic fields to moderate nerve activity and reduce the perception of pain by the human brain. The device sends signals at a frequency of 1 kHz into the site of pain to keep the brain from getting used to the stimulus.

4. BurstDR Stimulation

BurstDR was designed by a physician to simulate the spinal cord by providing “bursts” of pulses with patterns similar to natural nerve impulse which is what distinguishes it from other spinal cord simulations (SCS).

This technology introduced the burst mode to keep the human body from adapting to SCS therapy and becoming tolerant to the simulation which is a common problem with SCS.

5. Virtual Reality

Virtual Reality environments engage patients in a full-body sensory experience. They are different from the usual movies and games because there are more interactions and immersions of the individuals and VR requires maximum attention from the brain.

Patients are made to wear VR headsets and dive into a 360-degree world of “Cool” where they can toss fish and play with otters in a breathtakingly beautiful landscape.

Image Source: https://pixabay.com/en/nerves-cells-dendrites-sepia-791393/


https://www.drtommacek.com/blog/5-new-technol...ain-relief

About Tom Macek, MD:

Dr. Tom Macek is a pain management specialist honored to provide custom care to men and women from in and around Fort Lauderdale, Florida. His personable nature combined with expertise gathered from nearly two decades in medical practice is why Dr. Macek is among the most highly sought-after pain care physicians in the region.

Education is of the utmost importance to Dr. Macek. His early studies took place at McGill University in Montreal and SUNY in Albany. He studied medicine at Zagreb Medical School in Croatia, where he also completed an internship.

Once Dr. Macek emigrated to America, he completed an internship in internal medicine at Albany Medical Center and a residency in anesthesiology at the University of Florida in Gainesville. He further refined his skills with a pain management fellowship at the University of Washington in Seattle.

Dr. Macek is board-certified in anesthesia and pain management. He continues to seek out opportunities to learn and broaden his understanding of the latest pain management tools and techniques.

Dr. Macek has recruited an excellent support staff. From nursing staff to the administrative team that keeps his office running, you can rest assured you’re in great hands during your visits. All team members share the same passion for individualized, compassionate care in a warm and welcoming environment.

If you’re struggling with pain and are looking for a path toward healthy, pain-free function, contact Dr. Macek’s office to book an appointment today. There’s no better time to begin, and scheduling is as simple as a quick phone call or a few moments using the online scheduling tool.

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 159

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 117

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 181

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 469

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

CleanSpark's $550 Million Notes Offering and Strategic Outlook

Updated Category News Views 320

CleanSpark, Inc. Unveils $550 Million Convertible Notes Offering CleanSpark, Inc. (NASDAQ: CLSK), a leader in Bitcoin mining, has announced the successful pricing of a significant offering of $550 million in aggregate principal amount of its 0.00% Convertible Senior Notes due 2030. This endeavor is strategically positioned to enhance the company's financial flexibility...

Continue Reading
Terviva and Idemitsu Team Up for Sustainable Aviation Innovation

Updated Category News Views 203

Terviva Partners with Idemitsu for Sustainable Aviation Fuels Terviva, Inc. is a trailblazer in agricultural innovation, working to cultivate pongamia, a highly sustainable crop, for various applications including food, feed, and fuel. Recently, Terviva has entered into a strategic partnership with Idemitsu Kosan Co., Ltd, a leader in integrated energy, to advance the...

Continue Reading
Transforming Invoice Processing: BERNER Group Adopts xSuite

Updated Category News Views 362

Transforming Invoice Processing at BERNER Group The SAP-certified, highly integrated solution meets all the requirements of German and European legislation on electronic invoices. In a significant move towards modern procurement efficiency, the BERNER Group has chosen to adopt xSuite's AI-driven invoice automation solution. This innovative decision aligns with their...

Continue Reading
Celebrating Gord Hicks: A Commitment to Youth Wellness

Updated Category News Views 265

Honoring Gord Hicks with the King Charles III Coronation Medal Gord Hicks C.M., the CEO of BGIS, has been honored with the King Charles III Coronation Medal, recognizing his extensive commitment to youth mental health advocacy. For a decade, Hicks has actively supported initiatives with Kids Help Phone, contributing significantly to the well-being of young Canadians. The...

Continue Reading
Cellebrite Sees Booming Growth with Higher Price Target Outlook

Updated Category News Views 224

Cellebrite's Growth Prospects Shine Brightly Recently, TD Cowen raised its price target for Cellebrite (NASDAQ: CLBT) shares from $20.00 to $23.00, signaling the company's strong growth potential. This update reflects an optimistic outlook that emerged from recent management discussions, which provided valuable insights into Cellebrite's strategic direction and market...

Continue Reading